URINARY HEXOSAMINIDASE IN PATIENTS WITH LUNG-CARCINOMA

被引：0
|
作者：
BRATTAIN, MG
KIMBALL, PM
DURANT, JR
PRETLOW, TG
SMITH, D
CARPENTER, J
MARKS, M
机构：
[1] UNIV ALABAMA, MED CTR, DEPT BIOCHEM, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, MED CTR, DEPT PATHOL, BIRMINGHAM, AL 35294 USA
[3] UNIV ALABAMA, MED CTR, DEPT MED, BIRMINGHAM, AL 35294 USA
[4] UNIV ALABAMA, MED CTR, CTR COMPREHENS CANC, BIRMINGHAM, AL 35294 USA
来源：
CANCER | 1979年 / 44卷 / 06期
关键词：
D O I：
10.1002/1097-0142(197912)44:6<2267::AID-CNCR2820440640>3.0.CO;2-M
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The specific activity of urinary hexosaminidase was determined in 58 patients with various histological types of lung carcinoma. Compared to an apparently healthy control population, 32/35 patients with widely disseminated disease showed elevated values and 18/23 patients with disease confined to the chest had normal hexosaminidase values. Detailed studies of 18 patients indicated that declining hexosaminidase values were associated with effective therapy; rising values generally accompanied progressive disease.
引用
收藏
页码：2267 / 2272
页数：6
相关论文
共 50 条
  • [41] DIFFERENTIATION OF PRIMARY OR METASTATIC LUNG-CARCINOMA BY PHOSPHOLIPID ANALYSIS - A NEW APPROACH FOR LUNG-CARCINOMA DIFFERENTIATION
    ITOH, K
    NATORI, H
    SUZUKI, A
    AKINO, T
    CANCER, 1986, 57 (07) : 1350 - 1357
  • [42] THE CONTRIBUTION OF DISCRIMINATION ANALYSIS TO THE DIAGNOSTIC DECISION IN PATIENTS WITH LUNG-CARCINOMA
    PROCHAZKA, J
    STULIKOVA, V
    SOBESLAVSKY, C
    DEYL, Z
    ELIAS, M
    HELBICH, P
    NEOPLASMA, 1989, 36 (03) : 333 - 341
  • [43] ASSOCIATED PRIMARY ESOPHAGEAL AND LUNG-CARCINOMA - A STUDY OF 39 PATIENTS
    FEKETE, F
    SAUVANET, A
    KAISSERIAN, G
    JAUFFRET, B
    ZOUARI, K
    BERTHOUX, L
    FLEJOU, JF
    ANNALS OF THORACIC SURGERY, 1994, 58 (03): : 837 - 842
  • [44] THE CONTRIBUTION OF DISCRIMINATION ANALYSIS TO THE DIAGNOSTIC DECISION IN PATIENTS WITH LUNG-CARCINOMA
    PROCHAZKA, J
    STULIKOVA, V
    SOBESLAVSKY, C
    DEYL, Z
    ELIAS, M
    HELBICH, P
    PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (04) : 544 - 544
  • [45] SURGICAL-TREATMENT OF LUNG-CARCINOMA IN YOUNG-PATIENTS
    ZAITSEV, VF
    SHUTKIN, VA
    MALAI, EF
    VESTNIK KHIRURGII IMENI I I GREKOVA, 1986, 137 (10): : 7 - 10
  • [46] SERUM CONCENTRATION OF SERINE PROTEASE INHIBITORS IN PATIENTS WITH LUNG-CARCINOMA
    PROKOPOWICZ, J
    DABROWSKA, M
    KEMONA, H
    ANNALES DE BIOLOGIE CLINIQUE, 1988, 46 (07) : 564 - 564
  • [47] SERUM LYSOZYME ACTIVITY IN PATIENTS WITH LUNG-CARCINOMA SUBJECTED TO RADIOTHERAPY
    PROKOPOWICZ, J
    KEMONA, H
    WYSOCKA, J
    KILUK, S
    NEOPLASMA, 1985, 32 (05) : 605 - 611
  • [48] SEQUENTIAL STAGING IN PRIMARY LUNG-CARCINOMA - STUDY OF 115 PATIENTS
    MINTZ, U
    DEMEESTER, TR
    REZAI, K
    MACMAHON, H
    SOVIK, C
    BITRAN, JD
    GOLOMB, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 9 - 9
  • [49] CLINICAL-FEATURES OF ADENOSQUAMOUS LUNG-CARCINOMA IN 127 PATIENTS
    SRIDHAR, KS
    BOUNASSI, MJ
    RAUB, W
    RICHMAN, SP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (01): : 19 - 23
  • [50] SURVIVAL OF PATIENTS WITH LUNG-CARCINOMA METASTATIC TO THE BRAIN - COMPARISON OF THERAPIES
    MCGUIRE, TJ
    SMITH, SB
    KERBY, GR
    FIXLEY, MS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 393 - 393
12345